Cargando…
Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72
BACKGROUND: The first crystal structure of the active μ opioid receptor (μOR) exhibited several unexplained features. The ligand BU72 exhibited many extreme deviations from ideal geometry, along with unexplained electron density. I previously showed that inverting the benzylic configuration resolved...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566028/ https://www.ncbi.nlm.nih.gov/pubmed/37817141 http://dx.doi.org/10.1186/s12915-023-01689-w |
_version_ | 1785118829600309248 |
---|---|
author | Munro, Thomas A. |
author_facet | Munro, Thomas A. |
author_sort | Munro, Thomas A. |
collection | PubMed |
description | BACKGROUND: The first crystal structure of the active μ opioid receptor (μOR) exhibited several unexplained features. The ligand BU72 exhibited many extreme deviations from ideal geometry, along with unexplained electron density. I previously showed that inverting the benzylic configuration resolved these problems, establishing revised stereochemistry of BU72 and its analog BU74. However, another problem remains unresolved: additional unexplained electron density contacts both BU72 and a histidine residue in the N-terminus, revealing the presence of an as-yet unidentified atom. RESULTS: These short contacts and uninterrupted density are inconsistent with non-covalent interactions. Therefore, BU72 and μOR form a covalent adduct, rather than representing two separate entities as in the original model. A subsequently proposed magnesium complex is inconsistent with multiple lines of evidence. However, oxygen fits the unexplained density well. While the structure I propose is tentative, similar adducts have been reported previously in the presence of reactive oxygen species. Moreover, known sources of reactive oxygen species were present: HEPES buffer, nickel ions, and a sequence motif that forms redox-active nickel complexes. This motif contacts the unexplained density. The adduct exhibits severe strain, and the tethered N-terminus forms contacts with adjacent residues. These forces, along with the nanobody used as a G protein substitute, would be expected to influence the receptor conformation. Consistent with this, the intracellular end of the structure differs markedly from subsequent structures of active μOR bound to G(i) protein. CONCLUSIONS: Later G(i)-bound structures are likely to be more accurate templates for ligand docking and modelling of active G protein-bound μOR. The possibility of reactions like this should be considered in the choice of protein truncation sites and purification conditions, and in the interpretation of excess or unexplained density. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-023-01689-w. |
format | Online Article Text |
id | pubmed-10566028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105660282023-10-12 Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72 Munro, Thomas A. BMC Biol Research Article BACKGROUND: The first crystal structure of the active μ opioid receptor (μOR) exhibited several unexplained features. The ligand BU72 exhibited many extreme deviations from ideal geometry, along with unexplained electron density. I previously showed that inverting the benzylic configuration resolved these problems, establishing revised stereochemistry of BU72 and its analog BU74. However, another problem remains unresolved: additional unexplained electron density contacts both BU72 and a histidine residue in the N-terminus, revealing the presence of an as-yet unidentified atom. RESULTS: These short contacts and uninterrupted density are inconsistent with non-covalent interactions. Therefore, BU72 and μOR form a covalent adduct, rather than representing two separate entities as in the original model. A subsequently proposed magnesium complex is inconsistent with multiple lines of evidence. However, oxygen fits the unexplained density well. While the structure I propose is tentative, similar adducts have been reported previously in the presence of reactive oxygen species. Moreover, known sources of reactive oxygen species were present: HEPES buffer, nickel ions, and a sequence motif that forms redox-active nickel complexes. This motif contacts the unexplained density. The adduct exhibits severe strain, and the tethered N-terminus forms contacts with adjacent residues. These forces, along with the nanobody used as a G protein substitute, would be expected to influence the receptor conformation. Consistent with this, the intracellular end of the structure differs markedly from subsequent structures of active μOR bound to G(i) protein. CONCLUSIONS: Later G(i)-bound structures are likely to be more accurate templates for ligand docking and modelling of active G protein-bound μOR. The possibility of reactions like this should be considered in the choice of protein truncation sites and purification conditions, and in the interpretation of excess or unexplained density. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-023-01689-w. BioMed Central 2023-10-10 /pmc/articles/PMC10566028/ /pubmed/37817141 http://dx.doi.org/10.1186/s12915-023-01689-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Munro, Thomas A. Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72 |
title | Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72 |
title_full | Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72 |
title_fullStr | Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72 |
title_full_unstemmed | Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72 |
title_short | Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72 |
title_sort | reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with bu72 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566028/ https://www.ncbi.nlm.nih.gov/pubmed/37817141 http://dx.doi.org/10.1186/s12915-023-01689-w |
work_keys_str_mv | AT munrothomasa reanalysisofamopioidreceptorcrystalstructurerevealsacovalentadductwithbu72 |